An observational study of the factor Xa inhibitors rivaroxaban and apixaban as reported to eight poison centers
HA Spiller, JB Mowry, A Aleguas Jr, JRK Griffith… - Annals of emergency …, 2016 - Elsevier
Study objective Rivaroxaban and apixaban are part of a new group of oral anticoagulants
targeting factor Xa and approved by the Food and Drug Administration in 2011 and 2012 …
targeting factor Xa and approved by the Food and Drug Administration in 2011 and 2012 …
[PDF][PDF] An Observational Study of the Factor Xa Inhibitors Rivaroxaban and Apixaban as Reported to Eight Poison Centers
S Schaeffer, MJ Casavant - Annals of Emergency Medicine, 2016 - researchgate.net
Study objective: Rivaroxaban and apixaban are part of a new group of oral anticoagulants
targeting factor Xa and approved by the Food and Drug Administration in 2011 and 2012 …
targeting factor Xa and approved by the Food and Drug Administration in 2011 and 2012 …
An Observational Study of the Factor Xa Inhibitors Rivaroxaban and Apixaban as Reported to Eight Poison Centers.
HA Spiller, JB Mowry, A Aleguas Jr… - Annals of Emergency …, 2015 - europepmc.org
Study objective Rivaroxaban and apixaban are part of a new group of oral anticoagulants
targeting factor Xa and approved by the Food and Drug Administration in 2011 and 2012 …
targeting factor Xa and approved by the Food and Drug Administration in 2011 and 2012 …
An Observational Study of the Factor Xa Inhibitors Rivaroxaban and Apixaban as Reported to Eight Poison Centers
HA Spiller, JB Mowry, A Aleguas, JRK Griffith… - Annals of Emergency …, 2016 - infona.pl
Rivaroxaban and apixaban are part of a new group of oral anticoagulants targeting factor Xa
and approved by the Food and Drug Administration in 2011 and 2012. These oral …
and approved by the Food and Drug Administration in 2011 and 2012. These oral …
An observational study of the Factor Xa inhibitors rivaroxaban and apixaban as reported to eight poison centers
HA Spiller, JB Mowry, A Aleguas, JRK Griffith… - Annals of emergency …, 2015 - safetylit.org
STUDY OBJECTIVE: Rivaroxaban and apixaban are part of a new group of oral
anticoagulants targeting factor Xa and approved by the Food and Drug Administration in …
anticoagulants targeting factor Xa and approved by the Food and Drug Administration in …
[引用][C] An Observational Study of the Factor Xa Inhibitors Rivaroxaban and Apixaban as Reported to Eight Poison Centers
HA Spiller, JB Mowry, A Aleguas, JRK Griffith… - Annals of Emergency …, 2016 - cir.nii.ac.jp
An Observational Study of the Factor Xa Inhibitors Rivaroxaban and Apixaban as Reported
to Eight Poison Centers | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
to Eight Poison Centers | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
An Observational Study of the Factor Xa Inhibitors Rivaroxaban and Apixaban as Reported to Eight Poison Centers
HA Spiller, JB Mowry, A Aleguas… - Annals of …, 2016 - annemergmed.com
Study objective Rivaroxaban and apixaban are part of a new group of oral anticoagulants
targeting factor Xa and approved by the Food and Drug Administration in 2011 and 2012 …
targeting factor Xa and approved by the Food and Drug Administration in 2011 and 2012 …
An observational study of the Factor Xa inhibitors rivaroxaban and apixaban as reported to eight poison centers
HA Spiller, JB Mowry, A Aleguas, JR Griffith… - Annals of emergency …, 2015 - academia.edu
An Observational Study of the Factor Xa Inhibitors Rivaroxaban and Apixaban as Reported to Eight Poison Centers
HA Spiller, JB Mowry, A Aleguas Jr… - Annals of …, 2016 - pubmed.ncbi.nlm.nih.gov
Study objective Rivaroxaban and apixaban are part of a new group of oral anticoagulants
targeting factor Xa and approved by the Food and Drug Administration in 2011 and 2012 …
targeting factor Xa and approved by the Food and Drug Administration in 2011 and 2012 …
An observational study of the Factor Xa inhibitors rivaroxaban and apixaban as reported to eight poison centers
HA Spiller, JB Mowry, A Aleguas, JRK Griffith… - Annals of emergency …, 2015 - safetylit.org
STUDY OBJECTIVE: Rivaroxaban and apixaban are part of a new group of oral
anticoagulants targeting factor Xa and approved by the Food and Drug Administration in …
anticoagulants targeting factor Xa and approved by the Food and Drug Administration in …